Search results
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoKey Takeaways
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
US News & World Report· 6 days agoThe germ involved in all three cases was Mycobacterium abscessus, explained a team led by Dr. Minh-Vu Nguyen, an infectious disease specialist at National Jewish Health in Denver. "Stem cell ...